• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Doctors don't have the data needed to give clear guidelines, but they can provide information about benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not face a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large population-based study of case control to assess the frequency of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was correct and to reduce any bias.

However, the researchers' study had its limitations. The most important issue was that they were unable to separate the effects of the medication from the effects of the disorder at hand. This limitation makes it difficult to know whether the small differences observed in the groups that were exposed are due to the use of medication or confounding by comorbidities. In addition, the researchers did not examine the long-term outcomes of offspring.

The study showed that infants whose mothers took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers did not take any medication during pregnancy or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications during early pregnancies could be offset by the greater benefits to both mother and baby from continuing treatment for the woman’s disorder. Doctors should discuss with their patients about this issue and, if possible, help them develop coping strategies that could reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are made in the absence of clear and authoritative evidence regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what research says on the topic as well as their own judgments for different Adhd medications each individual patient.

In particular, the issue of possible risks to the infant can be difficult. The research on this subject is based on observations rather than controlled studies and many of the findings are conflicting. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.

The conclusion is that while some studies have shown a positive association between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slightly negative impact. In every case it is imperative to conduct a thorough evaluation of the potential risks and benefits should be conducted.

For many women with ADHD and ADD, the decision to stop medication is difficult if not impossible. In an article recently published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can general practitioners prescribe adhd medication cause depression, feelings of isolation and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to do job-related tasks and drive safely, which are important aspects of a normal life for many people suffering from ADHD.

She suggests women who are unsure about whether to keep or stop medication in light of their pregnancy, visit the website consider informing family members, friends and colleagues about the condition, its impact on daily life, and the advantages of staying on the current treatment regimen. It can also aid in ensuring that the woman feels supported in her struggle with her decision. It is important to remember that some medications can be absorbed through the placenta so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the medication could be transferred to the infant.

Risk of Birth Defects

As the use and use of adhd medication names uk drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two huge data sets to study more than 4.3 million pregnancy and determine if the use of stimulant medications increased birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects like ventriculo-septal defects (VSD).

The researchers of the study did not discover any connection between early medication usage and other congenital anomalies such as facial deformities or club feet. The results are in agreement with previous studies that showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication before the birth of their child. This risk increased during the latter part of pregnancy, when a lot of women decide to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely require a caesarean delivery, have an insufficient Apgar after delivery, and have a baby that needed help breathing after birth. The researchers of the study could not eliminate selection bias because they limited their study to women who can prescribe medication for adhd did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their study will inform physicians when they encounter pregnant women. The researchers recommend that, while discussing the risks and benefits are important, the decision about whether to continue or stop medication should be based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that while discontinuing the medications is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health problems in women who are pregnant or who are recently post-partum. Research has also shown that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments and preparing for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed by breast milk in very small amounts, so the risk to nursing infant is very low. However, the rate of medication exposure to the newborn can vary depending on the dosage, frequency it is administered and at what time the medication is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on a newborn's health is not fully known.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. It is a difficult decision for the mother, who must weigh the advantages of taking her medication as well as the risk to the fetus. In the meantime, until more information is available, doctors may ask pregnant patients if they have a history of ADHD or if they plan to take medication in the perinatal phase.

Numerous studies have demonstrated that women can continue taking their best adhd medication for women medication without risk while breastfeeding and during pregnancy. This has led to more and more patients choose to do so and in consultation with their physician, they have discovered that the benefits of maintaining their current medication outweigh any risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women with adhd no medication understand the symptoms and the underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for indicators of deterioration, and, if needed, adjustments to the medication regime.